
<meta data-rh="true" name="docsearch:language" content="en">
<meta data-rh="true" name="docsearch:version" content="current">
<meta data-rh="true" name="docsearch:docusaurus_tag" content="docs-default-current">
        ---
sidebar_position: 75
---
           <p class="stitle-article-norm">Corrective measures to be taken by Member&nbsp;States and information exchange between Member&nbsp;States</p>
   <p class="norm">1.&nbsp;&nbsp;Where a Member&nbsp;State in which a 
clinical investigation is being or is to be conducted has grounds for 
considering that the requirements set out in this Regulation are not 
met, it may take at least any of the following measures on its 
territory:</p>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(a)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">revoke the authorisation for the clinical investigation;</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(b)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">suspend or terminate the clinical investigation;</p>
      </div>
   </div>
   <div class="grid-container grid-list">
      <div class="list grid-list-column-1">
         <span>(c)&nbsp;</span>
      </div>
      <div class="grid-list-column-2">
         <p class="norm">require the sponsor to modify any aspect of the clinical investigation.</p>
      </div>
   </div>
   <p class="norm">2.&nbsp;&nbsp;Before the Member&nbsp;State concerned 
takes any of the measures referred to in paragraph&nbsp;1 it shall, 
except where immediate action is required, ask the sponsor or the 
investigator or both for their opinion. That opinion shall be delivered 
within seven days.</p>
   <p class="norm">3.&nbsp;&nbsp;Where a Member&nbsp;State has taken a 
measure referred to in paragraph&nbsp;1 of this Article&nbsp;or has 
refused a clinical investigation, or has been notified by the sponsor of
 the early termination of a clinical investigation on safety grounds, 
that Member&nbsp;State shall communicate the corresponding decision and 
the grounds therefor to all Member&nbsp;States and the Commission by 
means of the electronic system referred to in Article&nbsp;73.</p>
   <p class="norm">4.&nbsp;&nbsp;Where an application is withdrawn by 
the sponsor prior to a decision by a Member&nbsp;State, that information
 shall be made available through the electronic system referred to in 
Article&nbsp;73 to all Member&nbsp;States and the Commission.</p>